Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Myocardial Ischemia

NCT00221182 is registered in ClinicalTrials.gov with Foundation for Biomedical Research and Innovation as lead sponsor.

NCT NCT00221182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00221182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I / II Clinical Trial Regarding Vascular Regeneration Therapy by Transplantation of Autologous Peripheral Blood Endothelial Progenitor Cells (CD34+ Cells) in No-Option Patients With Chronic Myocardial Ischemia
Lead sponsor
Foundation for Biomedical Research and Innovation
Phase
Phase 1/2
Overall status
Terminated
Start date
September 30, 2005
Completion date
September 30, 2009
Enrollment
1 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

angina, chest pain, chronic myocardial ischemia, coronary artery disease, myocardial infarction